Kimberly A. Reske

3.5k citations

58 papers · 2.6k indexed · h-index 25

Infectious Diseases top 0.5%
Epidemiology top 2%
Critical Care and Intensive Care Medicine top 0.5%
Surgery top 10%
Molecular Biology

Co-authors: Erik R. Dubberke Victoria J. Fraser Margaret A. Olsen L. Clifford McDonald Yan Yan Christian D. Stone Da Hea Seo Carey‐Ann D. Burnham
Topics: Clostridium difficile and Clostridium perfringens research (41 papers)Microscopic Colitis (23 papers)Nosocomial Infections in ICU (15 papers)
Cited by: Infectious Diseases Critical Care and Intensive Care Medicine Epidemiology
Journals: Journal of Clinical InvestigationSHILAP Revista de lepidopterologíaClinical Infectious Diseases
Partner nations: United States India Japan

In The Last Decade

Kimberly A. Reske

56 papers receiving 2.5k citations

Peers

Countries citing papers authored by Kimberly A. Reske

Since Specialization

Citations

This map shows the geographic impact of Kimberly A. Reske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly A. Reske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly A. Reske more than expected).

Fields of papers citing papers by Kimberly A. Reske

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly A. Reske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly A. Reske. The network helps show where Kimberly A. Reske may publish in the future.

Co-authorship network of co-authors of Kimberly A. Reske

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly A. Reske. A scholar is included among the top collaborators of Kimberly A. Reske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly A. Reske. Kimberly A. Reske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Commensal-pathogen dynamics structure disease outcomes during Clostridioides difficile colonization 2024 ·Cell Host & Microbe ·Skye R. S. Fishbein,(unknown),(unknown),Aura Ferreiro,(unknown),(unknown),Jie Ning,Bejan Mahmud,Miranda J. Wallace,Tiffany Hink,Kimberly A. Reske,Candice Cass,Janaki L. Guruge,(unknown),Sunaina Rengarajan,Erik R. Dubberke,Gautam Dantas	4
2	Risk factors for hospital-onset Clostridioides difficile infections before and during the severe acute respiratory syndrome coronavirus 2 pandemic 2023 ·American Journal of Infection Control ·Jennie H. Kwon,Katelin B. Nickel,Kimberly A. Reske,Dustin Stwalley,Patrick G. Lyons,Andrew P. Michelson,Kathleen McMullen,John M. Sahrmann,Sumanth Gandra,Margaret A. Olsen,Erik R. Dubberke,Jason P. Burnham	2
3	Personal protective equipment use among dental healthcare personnel during the coronavirus disease 2019 (COVID-19) pandemic and the impact of an educational video in clinical practice 2023 ·Infection Control and Hospital Epidemiology ·(unknown),Kimberly A. Reske,Daniel Park,(unknown),(unknown),Olivia G. Arter,(unknown),(unknown),Stephen Y. Liang,Michael J. Durkin,Jennie H. Kwon	3
4	Early coronavirus disease 2019 (COVID-19) pandemic effects on individual-level risk for healthcare-associated infections in hospitalized patients 2023 ·Infection Control and Hospital Epidemiology ·(unknown),(unknown),Katelin B. Nickel,(unknown),Dustin Stwalley,Kimberly A. Reske,Jennie H. Kwon,Margaret A. Olsen,Jason P. Burnham,Erik R. Dubberke,Cristina Lanzas	2
5	Microbiology Clinical Culture Diagnostic Yields and Antimicrobial Resistance Proportions before and during the COVID-19 Pandemic in an Indian Community Hospital and Two US Community Hospitals 2023 ·Antibiotics ·Sumanth Gandra,Gerardo Alvarez‐Uria,Dustin Stwalley,Katelin B. Nickel,Kimberly A. Reske,Jennie H. Kwon,Erik R. Dubberke,Margaret A. Olsen,Jason P. Burnham	8
6	Epidemiology of Plasmid Lineages Mediating the Spread of Extended-Spectrum Beta-Lactamases among Clinical Escherichia coli 2022 ·mSystems ·Bejan Mahmud,Meghan A. Wallace,Kimberly A. Reske,(unknown),(unknown),David A. Rasmussen,Carey‐Ann D. Burnham,Cristina Lanzas,Erik R. Dubberke,Gautam Dantas	18
7	Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults 2022 ·Cell Reports ·Winston Anthony,Bin Wang,Kimberley V. Sukhum,Alaric W. D’Souza,Tiffany Hink,Candice Cass,Sondra Seiler,Kimberly A. Reske,(unknown),Erik R. Dubberke,Carey‐Ann D. Burnham,Gautam Dantas,Jennie H. Kwon	121
8	Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients 2021 ·mSphere ·Skye R. S. Fishbein,Tiffany Hink,Kimberly A. Reske,Candice Cass,(unknown),(unknown),Sondra Seiler,Jennie H. Kwon,Carey‐Ann D. Burnham,Gautam Dantas,Erik R. Dubberke	24
9	A randomized controlled trial of Lactobacillus rhamnosus GG on antimicrobial-resistant organism colonization 2021 ·Infection Control and Hospital Epidemiology ·Adriana M. Rauseo,Tiffany Hink,Kimberly A. Reske,Sondra Seiler,Kerry M. Bommarito,Victoria J. Fraser,Carey‐Ann D. Burnham,Erik R. Dubberke	9
10	Assessment of antibiotic-resistant organism transmission among rooms of hospitalized patients, healthcare personnel, and the hospital environment utilizing surrogate markers and selective bacterial cultures 2020 ·Infection Control and Hospital Epidemiology ·Jennie H. Kwon,Kimberly A. Reske,Caroline A. O’Neil,Candice Cass,Sondra Seiler,Meghan A. Wallace,Tiffany Hink,Stephen Y. Liang,Victoria J. Fraser,Carey‐Ann D. Burnham,Erik R. Dubberke	2
11	Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections 2019 ·mBio ·Robert Thänert,Kimberly A. Reske,Tiffany Hink,Meghan A. Wallace,Bin Wang,Drew J. Schwartz,Sondra Seiler,Candice Cass,Carey‐Ann D. Burnham,Erik R. Dubberke,Jennie H. Kwon,Gautam Dantas	80
12	Impact of Amoxicillin-Clavulanate followed by Autologous Fecal Microbiota Transplantation on Fecal Microbiome Structure and Metabolic Potential 2018 ·mSphere ·(unknown),Amy Langdon,Tiffany Hink,Meghan A. Wallace,Kimberly A. Reske,Sanket Patel,Xiaoqing Sun,Sondra Seiler,(unknown),Jennie H. Kwon,Carey‐Ann D. Burnham,Gautam Dantas,Erik R. Dubberke	15
13	Evaluation of Correlation between Pretest Probability for Clostridium difficile Infection and Clostridium difficile Enzyme Immunoassay Results 2016 ·Journal of Clinical Microbiology ·Jennie H. Kwon,Kimberly A. Reske,Tiffany Hink,Carey‐Ann D. Burnham,Erik R. Dubberke	11
14	An Evaluation of Food as a Potential Source forClostridium difficileAcquisition in Hospitalized Patients 2016 ·Infection Control and Hospital Epidemiology ·Jennie H. Kwon,Cristina Lanzas,Kimberly A. Reske,Tiffany Hink,Sondra Seiler,Kerry M. Bommarito,Carey‐Ann D. Burnham,Erik R. Dubberke	10
15	Risk Factors for Acquisition and Loss of Clostridium difficile Colonization in Hospitalized Patients 2015 ·Antimicrobial Agents and Chemotherapy ·Erik R. Dubberke,Kimberly A. Reske,Sondra Seiler,Tiffany Hink,Jennie H. Kwon,Carey‐Ann D. Burnham	51
16	Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients 2015 ·Infection Control and Hospital Epidemiology ·Jennie H. Kwon,Kerry M. Bommarito,Kimberly A. Reske,Sondra Seiler,Tiffany Hink,Hilary M. Babcock,Marin H. Kollef,Victoria J. Fraser,Carey‐Ann D. Burnham,Erik R. Dubberke	23
17	Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study 2014 ·BMC Infectious Diseases ·Marya D. Zilberberg,Kimberly A. Reske,Margaret A. Olsen,Yan Yan,Erik R. Dubberke	50
18	The Impact of ICD-9-CM Code Rank Order on the Estimated Prevalence of Clostridium difficile Infections 2011 ·Clinical Infectious Diseases ·Erik R. Dubberke,Anne M. Butler,(unknown),Kimberly A. Reske,Deborah S. Yokoe,Jeanmarie Mayer,Julie E. Mangino,Younis Mohd Khan,Victoria J. Fraser	34
19	Short- and Long-Term Attributable Costs of Clostridium difficile-Associated Disease in Nonsurgical Inpatients 2008 ·Clinical Infectious Diseases ·Erik R. Dubberke,Kimberly A. Reske,Margaret A. Olsen,L. Clifford McDonald,Victoria J. Fraser	146
20	Severity of Clostridium difficile–Associated Disease (CDAD) in Allogeneic Stem Cell Transplant Recipients: Evaluation of a CDAD Severity Grading System 2007 ·Infection Control and Hospital Epidemiology ·Erik R. Dubberke,Justin S. Sadhu,(unknown),Kimberly A. Reske,John F. DiPersio,Steven M. Devine,Victoria J. Fraser	32

About Kimberly A. Reske

Kimberly A. Reske is a scholar working on Critical Care and Intensive Care Medicine, Infectious Diseases and General Dentistry, having authored 58 papers that have together received 2.6k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (41 papers), Microscopic Colitis (23 papers) and Nosocomial Infections in ICU (15 papers). The work is most often cited by research in Infectious Diseases (2.0k citations), Critical Care and Intensive Care Medicine (557 citations) and Epidemiology (1.6k citations). Kimberly A. Reske has collaborated with scholars based in United States, India and Japan. Frequent co-authors include Erik R. Dubberke, Victoria J. Fraser, Margaret A. Olsen, L. Clifford McDonald, Yan Yan, Christian D. Stone, Da Hea Seo, Carey‐Ann D. Burnham, Tiffany Hink and Jennie H. Kwon. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Clinical Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact